ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,31
-0,26%
Dow Jones
39 883,18
0,03%
DAX
18 707,28
-0,10%
Brent Oil
83,405
0,24%
Bitcoin
67 145,51
2,92%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) Actualités

MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MRNS
DateHeureSourceTitreSymboleSociété
17/05/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
17/05/202413h00Business WireMarinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex ProgramNASDAQ:MRNSMarinus Pharmaceuticals Inc
08/05/202413h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
08/05/202413h00Business WireMarinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/05/202414h00Business WireMarinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
01/05/202414h00Business WireMarinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
15/04/202413h00Business WireMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
05/04/202422h00Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
27/03/202413h41Business WireMarinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant ReviewNASDAQ:MRNSMarinus Pharmaceuticals Inc
05/03/202422h14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRNSMarinus Pharmaceuticals Inc
05/03/202422h01Business WireMarinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
22/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
21/02/202413h00Business WireMarinus Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:MRNSMarinus Pharmaceuticals Inc
20/02/202413h00Business WireMarinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
14/02/202422h18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
04/01/202413h01Business WireMarinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY® Net Product Revenue and Provides Business UpdateNASDAQ:MRNSMarinus Pharmaceuticals Inc
20/11/202322h01Business WireMarinus Pharmaceuticals Announces Seven Presentations at AES 2023, New Publication in Epilepsia and Results From the Second Generation Formulation MAD StudyNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202322h05Business WireMarinus Pharmaceuticals to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
07/11/202313h01Business WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
07/11/202313h00Business WireMarinus Pharmaceuticals Initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CVNASDAQ:MRNSMarinus Pharmaceuticals Inc
24/10/202313h01Business WireMarinus Pharmaceuticals to Provide Business Update and Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/10/202322h01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRNSMarinus Pharmaceuticals Inc
21/09/202322h00Business WireMarinus Pharmaceuticals to Present at the 2023 Cantor Global Healthcare ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
19/09/202314h00Business WireMarinus Pharmaceuticals Highlights Advancing Pipeline and Commercial Strategy at Investor and Analyst Event NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/09/202322h00Business WireMarinus Pharmaceuticals Announces Speakers for Hybrid Investor & Analyst Event on Tuesday, September 19, 2023NASDAQ:MRNSMarinus Pharmaceuticals Inc
17/08/202322h01Business WireMarinus Pharmaceuticals to Host Hybrid Investor & Analyst Event on Tuesday, September 19, 2023NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/08/202313h01Business WireMarinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
31/07/202313h01Business WireMarinus Pharmaceuticals Announces European Commission Approval of ZTALMY® (ganaxolone) for the Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency DisorderNASDAQ:MRNSMarinus Pharmaceuticals Inc
27/07/202313h01Business WireMarinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023NASDAQ:MRNSMarinus Pharmaceuticals Inc
29/06/202312h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MRNSMarinus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MRNS

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
PX4
SBF 120
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
EU
ML
Michelin
EU
CS
Axa
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
EU
EN
Bouygues
NASDAQ
GOOGL
Alphabet
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés